CBER Poised for Research Shakeup As Prasad Makes Unproven Claims About ‘Polluted Science’

 
• By Sarah Karlin-Smith
  
CBER Director Vinay Prasad seems intent on revamping CBER's research agenda. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Agency Leadership

More from Cell & Gene Therapies